It’s hard to hear Drew Greenblatt over the steady - and deafening - ka-chink, ka-chunk of machines snipping steel wire at his factory in Southwest Baltimore. So he turns it up a notch."That’s for Baxter,” he hollers, pointing to a giant box full of special-ordered wire baskets ready to be shipped to the drugmaker. Nearby, an employee welds wire for biotech bigwig Amgen Inc. as Greenblatt ticks off a Who’s Who list of his other pharmaceutical customers: Pfizer, Roche, Novartis.
